Development and optimization of gastro retentive floating tablets of dapsone for controlled release

Rushikesh Mahale; Shivraj Jadhav; Sunil Mahajan

doi:10.56782/pps.551

Published : 2025-09-01

No. 2025 (Early Access)

Development and optimization of gastro retentive floating tablets of dapsone for controlled release

Rushikesh Mahale

Shivraj Jadhav

Sunil Mahajan

DOI: https://doi.org/10.56782/pps.551

Abstract

The objective of this study was to develop and optimize gastroretentive floating tablets of dapsone using a Quality by Design approach to enhance therapeutic efficacy in leprosy treatment. The tablets were prepared by direct compression using a 3² factorial design, with HPMC K15M (150–250 mg) and NaHCO₃ (15–25 mg) as independent variables. The formulations were evaluated for compression parameters, floating characteristics, and drug release profiles, with optimization focused on floating lag time (Y₁) and drug release at 12 hours (Y₂) as key responses. Further studies assessed release kinetics, formulation stability, and comparison with a marketed product. The optimized formulation (RF3), composed of 150 mg HPMC K15M and 25 mg NaHCO₃, exhibited excellent flow properties (Carr’s index: 15.25%, angle of repose: 26.84°), desirable floating behaviour (lag time: 64 seconds, duration: 11.4 hours), and sustained drug release (98.4% over 12 hours). The drug release followed the Higuchi model (R² = 0.9975) with a non-Fickian transport mechanism (n = 0.75). Stability studies under accelerated conditions (40 °C/75% RH for 6 months) confirmed drug content retention of 98.24% and a consistent release profile (97.4% at 12 hours). Overall, the optimized gastroretentive floating tablet formulation demonstrated satisfactory in vitro performance and stability, suggesting promising advantages over conventional dosage forms through extended gastric retention and controlled drug release. While these findings support the potential of this novel formulation for modified dapsone delivery, comprehensive in vivo studies are necessary to validate its therapeutic benefits over existing therapies.

Keywords:

Dapsone, Gastroretentive drug delivery, Floating tablets, Quality by Design

Similar Articles

Lucky Vasave, Shivraj Jadhav, Rushikesh Bachhav, Sunil Mahajan, Deepak Sonawane, A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Pratiksha Nahar, Dinesh Patil, Yash Bachhav, Jayesh Musale, Pallavi Bachhav, Design and Characterization of a Gastro-Retentive Floating Atorvastatin Calcium Tablet , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Sailaja Gunnam, Sindhura T, Rajeswari Aleti, Monika Nijhawan, Bi-layer tablets of sitagliptin phosphate & metformin hydrochloride – preparation and evaluation , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Michalina Skóra, Michał Nowacki, Maciej Dawidowski, Sulfoximine Derivatives — Their Pharmacochemical Properties, Synthesis, and Potential in Drug Discovery , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Priya Jagtap, Dr. Reshma Jadhav, Dr. Ashish Jain, Bhavesh Mahajan, Prapti Gawand, Prathamesh Chaudhari, Aishwarya Patil, QUALITY BY DESIGN APPROACH IN HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF ABIRATERONE ACETATE AND PREDNISOLONE WITH GREENNESS ASSESSMENT , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Komal Parmar, Rishi Bharatia, Novel flucytosine loaded in-situ gel for the management of ocular infections , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Wishah Nadeem, Sadaf Ahmad, Muneeb Ur Rahman, Habiba Akram, Usman Abdullah, Nanostructured lipid carriers applications in cosmeceuticals: structure, formulation, safety profile and market trends , Prospects in Pharmaceutical Sciences: Vol. 23 No. 2 (2025)
Agnieszka Kalicka, Natalia Tarłowska, Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Prathamesh V Chaudhari, Reshma Jadhav, Ashish Jain, Priya D Jagtap, Bhavesh D Mahajan, Prapti Gawand, A comprehensive review on drug-induced diseases and teratogenicity , Prospects in Pharmaceutical Sciences: Vol. 23 No. 1 (2025)
Vidya Patil, “DEVELOPMENT AND OPTIMIZATION OF DANAZOL CO-CRYSTAL LOADED TABLET TO TREAT ENDOMETRIOSIS” , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)

1 2 3 4 5 6 7 8 9 10 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Mahale, R., Jadhav, S., & Mahajan, S. (2025). Development and optimization of gastro retentive floating tablets of dapsone for controlled release . Prospects in Pharmaceutical Sciences, (2025 (Early Access). https://doi.org/10.56782/pps.551

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

[1] World Health Organization. Interruption of transmission and elimination of leprosy disease. 2023.

[2] Chen YZ, Li WH, Wu Q, Liu Y, Wang XM, Xu YY, et al. Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China. BMC Infect Dis. 2017;17(1):844. https://doi.org/10.1186/s12879-017-2869-8

[3] Temiz SA, Daye M. Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits? Cutan Ocul Toxicol. 2022;41(1):60–66. https://doi.org/10.1080/15569527.2021.2024565.

[4] Platsidaki E, Kontochristopoulos G. Dapsone. In: Katsambas AD, Lotti TM, Dessinioti C, D’Erme AM, editors. European Handbook of Dermatological Treatments. Cham: Springer; 2023. p. 1645–1651. https://doi.org/10.1007/978-3-031-15130-9-145.

[5] Khalilzadeh M, Shayan M, Jourian S, Rahimi M, Sheibani M, Dehpour AR. A comprehensive insight into the anti-inflammatory properties of dapsone. Naunyn Schmiedebergs Arch Pharmacol. 2022;395:1509–1523. https://doi.org/10.1007/s00210-022-02297-1.

[6] Chaudhari KD, Nimbalwar MG, Singhal NS, Panchale WA, Manwar JV, Bakal RL. Comprehensive review on characterizations and application of gastro-retentive floating drug delivery system. GSC Adv Res Rev. 2021;7:35–44.

[7] Mora-Castaño G, Domínguez-Robles J, Himawan A, Millán-Jiménez M, Caraballo I. Current trends in 3D printed gastroretentive floating drug delivery systems: A comprehensive review. Int J Pharm. 2024:124543.

[8] Vinchurkar K, Sainy J, Khan MA, Sheetal M, Mishra DK, Dixit P. Features and facts of a gastroretentive drug delivery system: a review. Turk J Pharm Sci. 2022;19(4):476–483.

[9] Attimarad M, Nair AB, Sreeharsha N, Al-Dhubiab BE, Venugopala KN, Shinu P. Development and validation of green UV derivative spectrophotometric methods for simultaneous determination of metformin and remogliflozin: evaluation of greenness. Int J Environ Res Public Health. 2021;18:448.

[10] Alburyhi MM, Hamidaddin MA, Noman MA, Saif AA, Yahya TA, Al-Ghorafi MA. Rivaroxaban-excipient compatibility studies for advanced drug delivery systems development. Eur J Pharm Med Res. 2024;11:370–404.

[11] Alburyhi MM, Noman MA, Saif AA, Al-Ghorafi MA, Yahya TA, Yassin SH, et al. Diclofenac-excipient compatibility studies for advanced drug delivery systems development. World J Pharm Res. 2024;13:1297–1333.

[12] Kuril AK. Differential scanning calorimetry: a powerful and versatile tool for analyzing proteins and peptides. J Pharm Res Int. 2024;36:179–187.

[13] Fatahi H, Claverie J, Poncet S. Thermal characterization of phase change materials by differential scanning calorimetry: A review. Appl Sci. 2022;12:12019.

[14] Parmar S, Patel J, Patel N, Patel A. Formulation development, optimization and in vitro evaluation of gas-based gastroretentive drug delivery system of anti-diabetic drug. World J Pharm Sci. 2022;10(6):64–83. https://doi.org/10.54037/WJPS.2022.100607.

[15] Pandey SK, Pudasaini J, Parajuli N, Singh RE, Shah KP, Adhikari A, et al. Formulation and evaluation of floating tablet of nimesulide by direct compression method. Magna Sci Adv Res Rev. 2024;10:153–161. 16.

[16] Chitte N, Jadhav S, Shinde S, Deshmukh A, Patil C. Formulation and evaluation of gastroretentive floating beads of valsartan. Cuest. fisioter. 2025;54(3):1813–1832. https://doi.org/10.3390/pharmaceutics15020709

[17] Gopaiah KV, Kumar JN, Teja MR, Lokesh T, Sruthi DS, Roja M, et al. Development and assessment of hydroxypropyl methylcellulose-based floating tablets for ciprofloxacin HCL using direct compression technique. J Pharm Res Int. 2024;36:47–62.

[18] Kunnath K, Chen L, Zheng K, Davé RN. Assessing predictability of packing porosity and bulk density enhancements after dry coating of pharmaceutical powders. Powder Technol. 2021;377:709–722.

[19] Kalman H. Bulk densities and flowability of non-spherical particles with mono-sized and particle size distributions. Powder Technol. 2022;401:117305.

[20] Schlick‐Hasper E, Bethke J, Vogler N, Goedecke T. Flow properties of powdery or granular filling substances of dangerous goods packagings, Comparison of the measurement of the angle of repose and the determination of the Hausner ratio. Packag Technol Sci. 2022;35:765–782. https://doi.org/10.1002/pts.2678.

[21] Kaleem MA, Alam MZ, Khan M, Jaffery SHI, Rashid B. An experimental investigation on accuracy of Hausner ratio and Carr index of powders in additive manufacturing processes. Met Powder Rep. 2021;76:S50–54.

[22] Jadhav SP, Ahire SM, Shewale VV, Patil CD, Pagar RY, Sonawane DD, et al. Formulation of tablet of nifedipine co-crystal for enhancement of solubility and other physical properties. Biosci Biotechnol Res Asia. 2025;22(1):191–200. http://dx.doi.org/10.13005/bbra/3353

[23] Ansari MH. Preclinical drug development process: formulation and development aspects. Int J Med Phar Sci. 2023;13:1.

[24] Asrade B, Tessema E, Tarekegn A. In vitro comparative quality evaluation of different brands of carbamazepine tablets commercially available in Dessie town, Northeast Ethiopia. BMC Pharmacol Toxicol. 2023;24:35. https://doi.org/10.1186/s40360-023-00670-1.

[25] Ukwueze SE, Jonathan CI, Ezeh IN, Oti IE, Chukwu DE, Chukwuogor C, et al. Formulation and evaluation of diazepam tablet from solidified self-emulsifying drug delivery system. World J Pharm Sci. 2021;9(12):150–161. https://doi.org/10.54037/WJPS.2021.91206

[26] Vetrivel D, Ilango KB, Bhuvaneswari S, Gomathi P, Kowsalya Devi M. In-vitro comparative study of generic vs branded tablets–A review. 2023.

[27] Sharma S, Gupta S, Bhardwaj B, Sahu A. A comparative analysis of metformin hydrochloride tablets, both branded and generic.

[28] Shimu SA. Comparative evaluation of atorvastatin 20mg tablets marketed in Bangladesh. PhD Thesis. Brac University. 2024.

[29] slam MR, Hossain MS, Hossain MS, Islam MT, Sultana S, Nijhum N, et al. Quality assessment of hydroxychloroquine tablet: A comparative evaluation of drug produced by different pharmaceutical companies in Bangladesh. Prog Microbes Mol Biol. 2023;6.

[30] Jadhav SP, Patil DM, Sonawane DD, Patil PD, Ghugarkar PG, Saad M. Formulation of tablet of ivermectin co-crystal for enhancement of solubility and other physical properties. J Pharm Negat Results. 2023;14(S1):513–20. https://doi.org/10.47750/pnr.2023.14.S01.60

[31] Won DH, Park H, Ha E-S, Kim H-H, Jang SW, Kim M-S. Optimization of bilayer tablet manufacturing process for fixed dose combination of sustained release high-dose drug and immediate release low-dose drug based on quality by design (QbD). Int J Pharm. 2021;605:120838.

[32] Vinchurkar K, Sainy J, Khan MA, Sheetal M, Mishra DK, Dixit P. Features and facts of a gastroretentive drug delivery system—a review. Turk J Pharm Sci. 2022;19:476.

[33] Kumar A, Srivastava R. In vitro in vivo studies on floating microspheres for gastroretentive drug delivery system: a review. Asian J Pharm Clin Res. 2021;14:13–26.

[34] Ranjan A, Jha PK. Studying drug release through polymeric controlled release formulations in United States Pharmacopoeia 2 apparatus using multiphysics simulation and experiments. Mol Pharm. 2021;18:2600–2611. https://doi.org/10.1021/acs.molpharmaceut.1c00086

[35] Javed QUA, Syed MA, Arshad R, Rahdar A, Irfan M, Raza SA, et al. Evaluation and optimization of prolonged release mucoadhesive tablets of dexamethasone for wound healing: In vitro–in vivo profiling in healthy volunteers. Pharmaceutics. 2022;14:807.

[36] González-González O, Ramirez IO, Ramirez BI, O’Connell P, Ballesteros MP, Torrado JJ, et al. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14:2324.

[37] Henninger B, Plaikner M, Zoller H, Viveiros A, Kannengiesser S, Jaschke W, et al. Performance of different Dixon-based methods for MR liver iron assessment in comparison to a biopsy-validated R2* relaxometry method. Eur Radiol. 2021;31:2252–2262. https://doi.org/10.1007/s00330-020-07291-w.

[38] González-González O, Ramirez IO, Ramirez BI, O'Connell P, Ballesteros MP, Torrado JJ, et al. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14(11):2324. https://doi.org/10.3390/pharmaceutics14112324.

[39] Zhou W, He Y, Liu F, Liao L, Huang X, Li R, et al. Carboxymethyl chitosan–pullulan edible films enriched with galangal essential oil: Characterization and application in mango preservation. Carbohydr Polym. 2021;256:117579.

[40] Aminu N, Chan S-Y, Mumuni MA, Umar NM, Tanko N, Zauro SA, et al. Physicochemical compatibility studies of triclosan and flurbiprofen with excipients of pharmaceutical formulation using binary, ternary, and multi-combination approach. Future J Pharm Sci. 2021;7:148. https://doi.org/10.1186/s43094-021-00302-7.

[41] Diño SF, Edu AD, Francisco RG, Gutierrez E, Crucis P, Lapuz AM, Carandang RR, Miranda KJ. Drug-excipient compatibility testing of cilostazol using FTIR and DSC analysis. Philipp J Sci. 2023;152(6A):2129–37. https://doi.org/10.56899/152.6A.08

[42] Almotairi N, Mahrous GM, Al-Suwayeh S, Kazi M. Design and optimization of lornoxicam dispersible tablets using quality by design (QbD) approach. Pharmaceuticals. 2022;15:1463.

[43] Bhatia V, Dhingra AK, Dass R, Chopra B, Guarve K. Formulation, development, and in-vitro evaluation of escitalopram fast dissolving tablets. Cent Nerv Syst Agents Med Chem. 2022;22:198–213.

[44] Al Hablawi MF, Jaffar IS. Formulation variables influencing the development of ketoconazole gastroretentive drug delivery system. Al-Rafidain J Med Sci. 2024;7:S15–23.

[45] Su’udiyah UF. The effect of ethyl cellulose 10 cps on the floating characteristic and ranitidine HCl release from floating tablet (using HPMC K15M matrix). Res J Pharm Technol. 2021;14:735–740.

[46] Jaimini R, Jaimini M. Formulation and optimization of gastro-retentive floating tablets of enalapril maleate and losartan for enhanced bioavailability and therapeutic efficacy. Trop J Pharm Life Sci. 2025;12:01–10.

[47] Moravkar KK, Shah DS, Magar AG, Bhairav BA, Korde SD, Ranch KM, et al. Assessment of pharmaceutical powders flowability and comparative evaluation of lubricants on development of gastro retentive tablets: An application of powder flow tester. J Drug Deliv Sci Technol. 2022;71:103265.

[48] Patel M, Shelke S, Surti N, Panzade P, Al-Keridis LA, Upadhyay TK, et al. Design, preparation, and in vitro evaluation of gastroretentive floating matrix tablet of mitiglinide. Front Pharmacol. 2023;14:1140351.

[49] Syed SM, Gawale K, Farooqui ZS. Formulation development and evaluation of gastro retentive matrix tablet of levamisole hydrochloride. Pharm Biosci J. 2021:50–70.

[50] Arpna I, Masheer KA. Box–Behnken design for optimization of formulation variables for controlled release gastroretentive tablet of verapamil hydrochloride. Int J Appl Pharm. 2023;15:256–263.

[51] Patel MB, Shaikh F, Patel VB, Surti N. Application of experiential design for framing gastroretentive microsponges of glipizide: Screening of critical variables by Plackett–Burman design and optimization by Box–Behnken design. Indian J Pharm Educ Res. 2021;55:966–978.

[52] Arpna I, Masheer KA. Box–Behnken design for optimization of formulation variables for controlled release gastroretentive tablet of verapamil hydrochloride. Int J Appl Pharm. 2023;15:256–263.

[53] Lee YS, Kang JS, Kim KM, Pyo JS. Optimization of ticagrelor tablet for gastro-retentive drug delivery using full factorial design. Trop J Pharm Res. 2024;23:235–242.

[54] Jadhav SP, Patil DM, Sonawane DD, Gaikwad VB, Patil PD, Ghugarkar PG. Formulation development and evaluation of orally disintegrating tablet of clopidogrel bisulphate. Int J Res Pharm Sci. 2023;14(1):505–12. https://doi.org/10.26452/ijrps.v14i1.5206

[55] Das S, Kaur S, Rai VK. Gastro-retentive drug delivery systems: A recent update on clinical pertinence and drug delivery. Drug Deliv Transl Res. 2021;11:1849–1857. https://doi.org/10.1007/s13346-020-00875-5.

[56] Raja HN, ud Din F, Shabbir K, Khan S, Alamri AH, Al Awadh AA, et al. Sodium alginate-based smart gastro-retentive drug delivery system of revaprazan loaded SLNs; Formulation and characterization. Int J Biol Macromol. 2023;253:127402.

[57] Mir A, Kumar A, Alam J, Riaz U. Synthesis and characterization of pH-responsive conducting polymer/Na-alginate/gelatin-based composite hydrogels for sustained release of amoxicillin drug. Int J Biol Macromol. 2023;252:126015.

[58] Nigusse B, Gebre-Mariam T, Belete A. Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride. PLoS One. 2021;16:e0253391.

[59] Sousa AS, Serra J, Estevens C, Costa R, Ribeiro AJ. Unveiling swelling and erosion dynamics: Early development screening of mirabegron extended release tablets. AAPS PharmSciTech. 2024;25:277. https://doi.org/10.1208/s12249-024-02994-5.

[60] Elkomy MH, Abou-Taleb HA, Eid HM, Yassin HA. Fabrication and in vitro/in vivo appraisal of metronidazole intra-gastric buoyant sustained-release tablets in healthy volunteers. Pharmaceutics. 2022;14:863.

[61] Xi Z. QbD approach for development of ivermectin-loaded gastro retentive sustained release tablets as mass drug administration for malaria transmission control [dissertation]. New York: St. John’s University; 2021. Available from: https://scholar.stjohns.edu/theses_dissertations/191

[62] González-González O, Ramirez IO, Ramirez BI, O’Connell P, Ballesteros MP, Torrado JJ, et al. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14:2324.

[63] Abdullah D, Saeed R, Ali M, Sohail M, Naeem S, Hussain T. Formulation and evaluation of mucoadhesive gastro-retentive tablets of domperidone. J Contemp Pharm. 2024;8:87–95.

[64] Yoshida T, Kojima H. Oral drug delivery systems applied to launched products: Value for the patients and industrial considerations. Mol Pharm. 2023;20:5312–5331. https://doi.org/10.1021/acs.molpharmaceut.3c00482.

[65] Kim DH, Lee S-W, Lee JH, Park JW, Park SM, Maeng H-J, et al. Development of gastroretentive floating combination tablets containing amoxicillin trihydrate 500 mg and levofloxacin 125 mg for eradicating resistant Helicobacter pylori. Pharmaceutics. 2024;16:1242.

[66] González-González O, Ramirez IO, Ramirez BI, O’Connell P, Ballesteros MP, Torrado JJ, et al. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14:2324.

Rushikesh Mahale

rushikeshkailasmahale@gmail.com

Affiliation:

a:1:{s:5:"en_US";s:63:"Divine college of pharmacy, Satana, Nashik, Maharashtra, India.";} India

Shivraj Jadhav

Affiliation:

Department of Pharmaceutics, Shreeshakti Shaikshanik Sanstha’s Divine College of Pharmacy, Nampur Road, Satana, Nashik, Maharashtra, India –42330 India

Sunil Mahajan

Affiliation:

Department of Pharmaceutical Chemistry, Shreeshakti Shaikshanik Sanstha’s Divine College of Pharmacy, Nampur Road, Satana, Nashik, Maharashtra, India –423301 India

Development and optimization of gastro retentive floating tablets of dapsone for controlled release

Rushikesh Mahale

Shivraj Jadhav

Sunil Mahajan

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Rushikesh Mahale

Shivraj Jadhav

Sunil Mahajan